The latest round of DBD patch notes finally tackle modifiers infinitely scaling, and the changes are live for those playing ...
This familiar phenomenon has puzzled researchers for centuries, but experiments are finally making sense of its unruly ...
MALVERN, Pa., March 24, 2026 (GLOBE NEWSWIRE)-- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced ...
Optimal dose intended for Phase 3 demonstrates statistically significant reduction in lesion growth (31%) versus control at 12 months (p< 0.05) Potential 2X treatment benefit compared to 15% and 22% ...
Your GBP isn't a directory listing anymore. If you're not actively feeding Google fresh signals every week, you're losing ground to competitors who are.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results